Latanoprost and Minoxidil: Comparative Double-Blind, Placebo-Controlled Study for the Treatment of Hair Loss

    January 2018 in “ Surgical and Cosmetic Dermatology
    Leila David Bloch, Cassiano Carlos Escudeiro, Fernanda Daud Sarruf, Neusa Yuriko Sakai Valente
    TLDR Latanoprost and minoxidil effectively control hair loss and increase hair count.
    A 180-day double-blind study compared the effectiveness of latanoprost and minoxidil in treating hair loss among 6 groups: placebo, 5% minoxidil, 5% minoxidil + 0.005% latanoprost, 0.005% latanoprost, 5% minoxidil + 0.010% latanoprost, and 0.010% latanoprost. Results showed significant improvement in hair strand count and anagen hair strands for groups treated with 5% minoxidil, 5% minoxidil + 0.005% latanoprost, 0.005% latanoprost, and 5% minoxidil + 0.010% latanoprost. The 0.010% latanoprost group did not show significant differences compared to the placebo. The study concluded that these treatments were effective in controlling hair loss and increasing the total number of hair strands.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 114 results

      community Cosmo Pharma Lists Breezula Phase 3 Trial on ClinicalTrials.gov

      in Research/Science  24 upvotes 1 year ago
      A phase 3 trial for Breezula (clascoterone solution) to treat male pattern hair loss has been listed, with 726 participants and a completion date of January 2025. Other treatments mentioned include Aneira Pharma's combination of minoxidil and latanoprost, Triple Hair's combination of minoxidil, latanoprost, and finasteride, and a new microneedling and LLLT device called StimuSIL.

    Related Research

    18 / 18 results